Asia Pacific Drug Discovery Market 2021-2030, Research Report, Size, Share, Trends, Demand, Growth, Revenue, Major Players, Future Outlook: Ken Research Buy Now According to the report analysis, ‘Asia Pacific Drug Discovery Market 2020-2030 by Drug Type (Small Molecule, Biologics), Service (Medicinal, Biological, DMPK), Process, Technology, Therapeutic Area, End User, and Country: Trend Forecast and Growth Opportunity’ states that Abbott Laboratories Inc., Agilent Technologies Inc., Astrazeneca plc, Bayer AG, Charles River Laboratories International Inc., Eli Lilly… Read More »
Increase in Number of Patients Suffering from Chronic Diseases Expected to Drive Asia Pacific AI in Drug Discovery Market: Ken Research Artificial intelligence technology for the drug discovery consists of various algorithms providing the value addition in the overall decision-making processes for the right drug discovery. The Artificial Intelligence based techniques are designed to assist manufacturers by providing easy solution for the complex situations. Further, AI based solutions are able to provide to new analytical approach… Read More »
Increase in Focus towards Boosting Pharmaceutical Capacities Expected to Drive Global Artificial Intelligence in Drug Discovery Market: Ken Research Artificial Intelligence or AI is a technological system, designed with a set of domains including solution research, reasoning, knowledge representation, machine learning to mimic the human intelligence. AI is usually used in the healthcare industry for drug-discovery. It has the ability to recognize the drug targets, and play an important role in drug design, identification,… Read More »
